[{"id":"bf802eaf-0ab2-414a-8f5e-a7298686c6fe","acronym":"IMMUNOCELL","url":"https://clinicaltrials.gov/study/NCT05044676","created_at":"2023-07-20T07:09:56.537Z","updated_at":"2024-07-02T16:35:37.179Z","phase":"","brief_title":"Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular Carcinoma","source_id_and_acronym":"NCT05044676 - IMMUNOCELL","lead_sponsor":"Assistance Publique - Hôpitaux de Paris","biomarkers":" CD226","pipe":"","alterations":" ","tags":["CD226"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Tecentriq (atezolizumab)"],"overall_status":"Recruiting","enrollment":" Enrollment 120","initiation":"Initiation: 09/08/2023","start_date":" 09/08/2023","primary_txt":" Primary completion: 09/08/2025","primary_completion_date":" 09/08/2025","study_txt":" Completion: 09/08/2027","study_completion_date":" 09/08/2027","last_update_posted":"2023-09-13"}]